Advances in the Treatment of HER2-Positive Breast Cancer

December 18, 2014
William J. Gradishar, MD

Special Reports, Breast Cancer (Issue 1), Volume 1, Issue 1

William J. Gradishar, MD, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.

William J. Gradishar, MD, Betsy Bramsen Professorship of Breast Oncology, Professor in Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, discusses advances in the last year in the treatment of patients with HER2-positive breast cancer.

<<<

Back to the Breast Cancer Special Report